Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesNIOX Group PLC

NIOX Group PLC

Healthcare Medical Devices
PortfolioPortfolio WatchlistWatchlist
Company price
69.0 GBX 2.00 ( 2.99%)
Last update at 2026-10-27T16:35:00Z
VOLUME
253075
Market Cap
235.79M
P/E
28.20

Momentum Score

…

NIOX Group Plc engages in the design, development, and commercialization of medical devices for asthma diagnosis, monitoring, and management worldwide. It offers NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of Fractional Exhaled Nitric Oxide (FeNO) level in patients. The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc in September 2022. NIOX Group Plc was incorporated in 2006 and is headquartered in Oxford, the United Kingdom.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
67.28
Low
70.00
High
52 Week Price Range
53.84
Low
77.60
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
67.00
Dividend Yield
2.83%
Revenue TTM
48.70M
Revenue Per Share
0.12
Gross Profit TTM
33.70M
Debt / Equity
0.01
ROE
11.02%
Net Debt
-18.90M
ROCE
15.71%
Diluted EPS TTM
0.02

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2023-12-30 2022-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2023-12-30 2022-12-31
Income before tax 11.20M 7.80M 4.10M 4.10M 10.50M
Net income 7.00M 3.70M 10.70M 10.70M 16.10M
Selling general administrative 20.40M 8.80M 8.40M 8.40M 7.50M
Selling and marketing expenses - 11.20M 11.20M 11.20M 9.70M
Gross profit 29.60M 30.20M 26.50M 26.50M 22.20M
Reconciled depreciation 4.10M 4.20M 4.40M - 4.60M
Ebit - 8.00M 4.20M 4.20M 10.60M
Ebitda 10.70M 12.20M 8.60M 8.60M 15.20M
Depreciation and amortization - 4.20M 4.40M 4.40M 4.60M
Operating income 10.70M 7.70M 4.60M 4.60M 1.80M
Other operating expenses 38.00M 34.10M 32.20M 32.20M 29.50M
Interest expense 0.20M 0.20M 0.20M 0.20M 0.10M
Tax provision 4.20M 4.30M -5.40M - -3.60M
Interest income 0.40M 0.90M 0.80M - 0.30M
Net interest income 0.20M 0.70M 0.60M - 0.00M
Income tax expense 4.20M 4.40M -5.40M -5.40M -3.60M
Total revenue 48.70M 41.80M 36.80M 36.80M 31.30M
Total operating expenses 18.90M 22.50M 21.90M 21.90M 20.40M
Cost of revenue 19.10M 11.60M 10.30M 10.30M 9.10M
Total other income expense net 0.50M 0.10M -0.50M -0.50M 8.70M
Net income from continuing ops 7.00M 3.40M 9.50M - 14.10M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2023-12-30 2022-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2023-12-30 2022-12-31
Total assets 76.20M 68.40M 91.50M 91.50M 98.50M
Intangible assets 23.80M 23.50M 28.20M 28.20M 32.40M
Other current assets - 6.20M - 4.70M -
Total liab 8.60M 8.90M 7.70M 7.70M 16.60M
Total stockholder equity 73.70M 59.50M 83.80M 83.80M 81.90M
Other current liab - 4.20M 4.10M 4.10M 6.70M
Common stock 0.30M 0.30M 0.30M 0.30M 0.30M
Capital stock 0.30M 0.30M 0.30M - 0.30M
Retained earnings 45.40M 43.40M 65.20M 65.20M -574.40M
Good will 4.80M 4.30M 4.60M 4.60M 4.70M
Cash 19.90M 10.90M 19.90M 19.90M 19.40M
Total current liabilities 8.10M 8.10M 7.20M 7.20M 9.20M
Current deferred revenue - - - -0.60M -
Net debt -18.90M -9.40M -18.80M -18.80M -18.40M
Short term debt 0.50M 1.40M 1.20M 1.20M 1.20M
Short long term debt total 1.00M 1.50M 1.10M 1.10M 1.00M
Other stockholder equity 0.30M 0.20M 0.10M 0.10M 639.40M
Total current assets 30.90M 21.10M 33.50M 33.50M 31.40M
Net receivables 6.00M 6.20M 8.80M 8.80M 7.90M
Inventory 5.00M 4.00M 4.80M 4.80M 4.10M
Accounts payable 7.60M 1.60M 1.10M 1.10M 0.50M
Accumulated other comprehensive income 27.70M 15.60M 18.20M 18.20M 16.60M
Non currrent assets other - - - 23.80M -
Non current assets total 45.30M 47.30M 58.00M 58.00M 67.10M
Capital lease obligations 1.00M 1.50M 1.10M - 1.00M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2023-12-30 2022-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2023-12-30 2022-12-31
Investments - -1.00M -0.30M - -0.10M
Total cashflows from investing activities -1.20M -1.00M -0.30M -0.30M -0.10M
Total cash from financing activities -5.50M -25.10M -10.50M -10.50M -0.50M
Net income 7.00M 8.10M 5.30M 5.30M 12.50M
Change in cash 9.00M -9.00M 0.50M 0.50M 6.80M
Begin period cash flow 10.90M 19.90M 19.40M 19.40M 12.60M
End period cash flow 19.90M 10.90M 19.90M 19.90M 19.40M
Total cash from operating activities 15.80M 17.20M 11.60M 11.60M 6.70M
Issuance of capital stock 0.10M 0.10M 0.10M - 0.00M
Depreciation 4.10M 4.20M 4.40M 4.40M 4.60M
Other cashflows from investing activities 0.30M - -0.20M -0.20M -
Dividends paid 5.00M 4.20M 10.50M 10.50M -
Change to inventory -0.70M 0.50M -0.80M -0.80M -1.40M
Change to account receivables 0.50M 2.80M 2.70M 2.70M -6.70M
Sale purchase of stock 0.00M -21.30M 0.00M - -
Other cashflows from financing activities -0.60M 0.80M 0.60M 0.60M 0.10M
Capital expenditures 0.20M 1.00M 0.30M 0.30M 0.10M
Change in working capital -0.40M 3.20M -0.60M -0.60M -10.70M
Stock based compensation 1.10M 1.90M 2.40M 2.40M 0.90M
Other non cash items 9.20M -0.20M 0.10M 0.10M -0.60M
Free cash flow 15.60M 16.20M 11.30M 11.30M 6.60M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(GBX)
Price
(GBX)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
NIOX
NIOX Group PLC		 2.00
2.99%		 69.00 28.20 18.73 4.84 3.41 4.35 13.85
SN
Smith & Nephew PLC		 -14.00
1.23%		 1122.50 23.24 12.47 1.70 2.59 2.67 10.76
EKF
EKF Diagnostics Holdings Plc		 -0.40
1.61%		 24.40 - 34.97 2.02 1.46 1.72 7.01
CREO
Creo Medical Group PLC		 -
-%		 11.25 - - 199.36 0.74 6.21 8.16
AOTI
AOTI Inc		 -1.00
0.77%		 129.00 18.25 8.10 0.64 2.76 0.94 8.31

Profile*

NIOX Group PLC

NIOX Group Plc engages in the design, development, and commercialization of medical devices for asthma diagnosis, monitoring, and management worldwide. It offers NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of Fractional Exhaled Nitric Oxide (FeNO) level in patients. The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc in September 2022. NIOX Group Plc was incorporated in 2006 and is headquartered in Oxford, the United Kingdom.

Magdalen Centre, Oxford, United Kingdom, OX4 4GA

44 3303 309 356

https://www.niox.com

97

Name Title Year Born
Mr. Ian Roy Johnson Exec. Chairman 1954
Mr. Michael Roy David Roller A.C.A., ACA, BA (Hons) CFO & Director 1965
Mr. Jonathan Emms COO & Exec. Director NA
Ms. Nina Kataria Sr. VP Global HR NA
Mr. Tom Scaccia Sr. VP of Americas & Research Bus. NA
Ms. Sarah Duncan Company Sec. NA
Mr. Jonathan Charles Emms CEO & Executive Director 1963
Ms. Sarah Elizabeth Duncan CFO & Company Secretary NA
Mr. Tom Scaccia Senior Vice President of Americas & Research Business NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

ITH
CAD 2.15
+27.68%
HG
CAD 4.11
+19.13%
PPTA
CAD 27.74
+17.99%
UCU
CAD 2.10
+17.32%
GAU
CAD 3.49
+16.72%
TSU
CAD 29.67
-29.71%
PXT
CAD 19.73
-16.91%
LAS-A
CAD 230.50
-9.25%
IFP
CAD 13.50
-8.35%
NFI
CAD 24.01
-7.80%

Equity Sectors*

  • Basic Materials

    +3.74%

  • Communication Services

    +0.56%

  • Consumer Cyclical

    -0.34%

  • Consumer Defensive

    +0.11%

  • Energy

    +1.33%

  • Financial Services

    -0.26%

  • Healthcare

    +2.54%

  • Industrials

    -0.11%

  • Real Estate

    -0.23%

  • Technology

    +1.91%

  • Utilities

    +1.05%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…